Literature DB >> 27010377

Effect of r-TMS over standard therapy in decreasing muscle tone of spastic cerebral palsy patients.

Meena Gupta1, Bablu Lal Rajak1, Dinesh Bhatia1, Arun Mukherjee2.   

Abstract

Spastic cerebral palsy (CP) is the one of most common neurological disorders occurring due to damage to the immature brain or any other brain lesion at the time of birth. To aid in making the life of the CP patient meaningful, several interventions such as medical, surgical and rehabilitation have been employed to date. Besides these, recently repetitive Transcranial magnetic stimulation (r-TMS) is a new found approach which is being employed for treating various neurological and psychological conditions. The aim of this study was to observe the effects of r-TMS on muscle spasticity in CP patients by stimulating the motor cortex area of the brain, which is responsible for muscle movements. In this study, 20 subjects diagnosed with CP were recruited and 10 each were placed in two groups, namely the research group (RG) (mean age, height and weight were 7.99 (SD = 4.66) years, 116.7 (SD = 23.57) cm and 21.40 (SD = 10.95) kg, respectively) and the control group (CG) (mean age, height and weight were 8.41 (SD = 4.32) years, 107.9 (SD = 26.33) cm, 21.40 (SD = 12.63) kg, respectively). r-TMS frequencies of 5 Hz and 10 Hz were administered for 15 min daily to patients in RG followed by standard therapy (ST) of 1 h duration daily for 20 days. Moreover, the patients in the control group (CG) were given only standard therapy (ST) of 1 h duration for 20 days. Modified Ashworth Scale (MAS) was used as an outcome measure to determine the level of muscle spasticity. A pre- assessment of MAS score was performed on both RG and CG to determine the level of spasticity prior to starting therapy; and similarly post-assessment after 20 days was done to observe the changes post-therapy. Statistical analysis of pre vs post MAS scores showed that few muscles showed reduction in muscle tightness after administering only ST in the CG. On the contrary, the RG that underwent r-TMS therapy combined with ST showed a significant decrease (p < 0.05) in muscle tightness for all the muscles selected for the therapy.

Entities:  

Keywords:  Repetitive Transcranial Magnetic Stimulation (r-TMS); Upper Motor Neuron (UMN); motor cortex; muscle tone; spasticity

Mesh:

Year:  2016        PMID: 27010377     DOI: 10.3109/03091902.2016.1161854

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  5 in total

1.  Efficacy of photobiomodulation therapy on masseter thickness and oral health-related quality of life in children with spastic cerebral palsy.

Authors:  Maria Teresa Botti Rodrigues Santos; Karla Santos Nascimento; Simone Carazzato; Alina Oliveira Barros; Fausto Medeiros Mendes; Michele Baffi Diniz
Journal:  Lasers Med Sci       Date:  2017-05-23       Impact factor: 3.161

2.  Morphologic Variants of the Hand Motor Cortex in Developing Brains from Neonates through Childhood Assessed by MR Imaging.

Authors:  F Wu; H Zhao; Y Zhang; M Wang; C Liu; X Wang; Y Cheng; C Jin; J Yang; X Li
Journal:  AJNR Am J Neuroradiol       Date:  2022-01-06       Impact factor: 3.825

3.  The Effect of Repetitive Transcranial Magnetic Stimulation on Spasticity in Patients with Multiple Sclerosis.

Authors:  Ayça Uran Şan; Bilge Yılmaz; Serdar Kesikburun
Journal:  J Clin Neurol       Date:  2019-10       Impact factor: 3.077

4.  Increasing Number of Therapy Sessions of Repetitive Transcranial Magnetic Stimulation Improves Motor Development by Reducing Muscle Spasticity in Cerebral Palsy Children.

Authors:  Bablu Lal Rajak; Meena Gupta; Dinesh Bhatia; Arun Mukherjee
Journal:  Ann Indian Acad Neurol       Date:  2019 Jul-Sep       Impact factor: 1.383

5.  Non-Invasive Brain Stimulation in Children With Unilateral Cerebral Palsy: A Protocol and Risk Mitigation Guide.

Authors:  Bernadette T Gillick; Andrew M Gordon; Tim Feyma; Linda E Krach; Jason Carmel; Tonya L Rich; Yannick Bleyenheuft; Kathleen Friel
Journal:  Front Pediatr       Date:  2018-03-16       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.